☸️ SAIMSARA — Public Sessions

GAE shows a strong 6-month pain-relief signal in single-arm studies, but conflicting sham-controlled trials challenge whether the benefit truly lasts beyond placebo at 1 year. The full review explains who may actually benefit, why less advanced radiographic arthritis predicts response, how embolic agents differ, and whether this minimally invasive option deserves a place in the knee OA treatment pathway.

Cerebral hyperperfusion syndrome is not just a rare post-procedural complication — it is a dangerous failure of cerebrovascular autoregulation when restored flow overwhelms chronically exhausted brain perfusion reserve. This full SAIMSARA read maps 475 original studies, 192 key references, and 477,299 observations to show where CHS risk emerges after carotid, moyamoya, bypass, thrombectomy, and posterior circulation revascularization — and why blood-pressure governance, perfusion monitoring, staged strategies, and seizure vigilance may decide the clinical outcome.

Central venous catheter infection prevention is not a single-product story: this review shows that sustained CLABSI/CRBSI reduction depends on maintenance bundles, chlorhexidine-based care, closed-access systems, daily line-necessity review, staff competency, and audit feedback working together. Built from 326 original studies and 608,263 participant/sample observations, the full read maps where infection rates fall by 42% to over 90%, where risk persists despite bundles, and which maintenance strategies are most clinically actionable across adult, pediatric, neonatal, oncology, and hemodialysis populations.

Fractional flow reserve is no longer just a coronary pressure number—it is a decision framework that reshapes revascularization, deferral, imaging, plaque assessment, and vascular risk stratification across clinical settings. This full read maps 3,488 original studies, 615 key references, and more than 42.4 million observations to show where FFR is reliable, where it fails, and why physiology must increasingly be combined with plaque and microvascular context.

Gender-affirming hormone therapy is not a single cardiovascular exposure: testosterone, estrogen route, anti-androgen choice, age, comorbidity, and monitoring all shift the risk picture. This full read maps 319 original studies, 114 key references, and more than 15.7 million observations to clarify where GAHT appears safer, where vascular risk signals emerge, and what clinicians should watch before relying on generic sex-based risk calculators.

This review shows that diving is not simply dangerous or beneficial, but a health-sensitive exposure where cardiac disease, obesity, barotrauma, decompression illness, and poor emergency planning define much of the risk. The full read maps 139 references across 273 original studies and over 105 million observations, clarifying when scuba, breath-hold, occupational, and therapeutic diving may be safe, harmful, or clinically useful.

This review shows that ramipril and candesartan are not simply interchangeable RAAS drugs: blood-pressure control is broadly comparable, but the evidence separates them by exercise BP response, tolerability, diastolic function, anti-fibrotic signals, and perioperative fibrinolytic effects. The full read maps 37 references across 33 original studies and 399,243 observations, clarifying where candesartan, ramipril, or single-pill combinations may offer the more rational clinical choice.

Pornography is not a single-risk exposure but a complex behavioral ecosystem where most users report neutral or positive effects, while a clinically important minority develop problematic use linked to mental distress, relationship conflict, risky sexual behavior, and aggression-related outcomes. The full read maps 318 references across 1,287 original studies, separating frequency from problematic use and showing where pornography literacy, couple context, moral incongruence, and targeted screening may actually matter.

Cryptocurrency is not only a speculative financial technology but a public-health exposure, linking trading volatility to gambling-like behavior, psychological distress, skipped medical care, and mining-related air pollution. The full read maps both sides of the evidence: where crypto harms mental and environmental health, and where blockchain infrastructure may still support secure health data, incentives, and healthcare governance.

CO2 angiography is not simply an “iodine-free alternative,” but a selective kidney-sparing imaging strategy with strongest value in CKD, contrast allergy, dialysis access, peripheral interventions, renal procedures, and EVAR. The full read clarifies where CO2 truly helps, where image quality fails—especially below the knee—and which rare but severe complications demand careful technique and patient selection.

This review shows that intravascular lithotripsy is no longer a niche calcium tool, but an expanding platform across coronary PCI, peripheral interventions, TAVR access, stent failure, and complex off-label vascular anatomy. The full read clarifies where IVL is best supported, where evidence is still case-based, and how procedural success, complications, imaging guidance, and long-term durability should shape real clinical use.

RAS/KRAS inhibition has finally moved from “undruggable” promise to therapeutic reality, but this review shows why single-agent targeting is rarely enough. The full read maps 705 original studies to clarify how allele-specific, pan-RAS, RAS(ON), combination, resistance-monitoring, and immune/radiotherapy strategies may shape the next generation of durable cancer control.